Article
A novel Chemokine-related LncRNA signature predicts the prognosis and immunotherapy response in lung adenocarcinoma patients
2023-06-30
Abstract excerpt
<h4>Background: </h4> Chemokines and their receptors are widely reported to be closely associated with cancer progression, especially in the immune microenvironment. However, studies on chemokine-related lncRNAs (CRLs) in lung adenocarcinoma (LUAD) have not been reported. This study aimed to construct a prognostic model based on CRL signature to explore their relationship with prognosis and immune infiltration in...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f30eb550-77ea-57a3-b504-2ac4d93ac777
- DOI
- 10.21203/rs.3.rs-3115047/v1
